Pterostilbene Dosage Guide: Protocols, Calculator & Safety

Pterostilbene combines thoughtfully with numerous supplements in longevity, cognitive, and metabolic supplementation regimens. Key stacking rationales:

Pterostilbene + NAD+ precursors (NR/NMN): This is the archetypal pterostilbene stack, commercialized as Elysium Health's Basis. The rationale combines NAD+ substrate provision (from NR or NMN) with direct SIRT1 activation from pterostilbene. Sirtuin enzymes require NAD+ as cosubstrate; providing both the substrate and an allosteric activator theoretically maximizes sirtuin-mediated effects. Typical doses: NR 250-500 mg + pterostilbene 50 mg daily, or NMN 250-500 mg + pterostilbene 100 mg daily.

Pterostilbene + resveratrol: Despite apparent redundancy, combining pterostilbene and resveratrol has theoretical logic: resveratrol has some SIRT1 activation patterns and tissue targets that differ from pterostilbene, and the combination may provide complementary polyphenol coverage. Practically, however, most of resveratrol's bioactivity can be captured by pterostilbene alone due to resveratrol's poor bioavailability. If resveratrol is used, typical doses are resveratrol 250-500 mg + pterostilbene 50-100 mg.

Pterostilbene + quercetin: Both polyphenols activate overlapping longevity pathways (SIRT1, AMPK, Nrf2), and quercetin also has mast cell stabilizing and anti-inflammatory properties that pterostilbene lacks. The combination is reasonable for users pursuing a comprehensive flavonoid stack. Typical doses: pterostilbene 50-100 mg + quercetin 500 mg daily.

Pterostilbene + fisetin: Both polyphenols with SIRT1 activation; fisetin adds superior senolytic potency and BBB penetration. A longevity-focused stack might use pterostilbene 50-100 mg daily (chronic dosing) + fisetin intermittent pulse dosing (1400 mg for 2 consecutive days monthly following AFFIRM-LITE protocol).

Pterostilbene + berberine: Both activate AMPK through distinct mechanisms and may produce complementary metabolic effects. Berberine is a more potent direct AMPK activator while pterostilbene adds SIRT1 and anti-inflammatory effects. Typical doses: pterostilbene 100-150 mg + berberine 500 mg 2-3x daily with meals.

Pterostilbene + metformin: Both activate AMPK; metformin more potently and systemically. Combination may be synergistic for metabolic effects. This combination is sometimes pursued by users with both longevity and glycemic optimization interests but requires physician supervision.

Pterostilbene + CoQ10: Pterostilbene promotes mitochondrial biogenesis; CoQ10 supports electron transport chain function. Reasonable pairing for mitochondrial support, particularly in older adults or those on statins.

Pterostilbene + PQQ: Both support mitochondrial function through complementary mechanisms. Some commercial formulations combine PQQ 20 mg + pterostilbene 50 mg for cognitive and mitochondrial support.

Pterostilbene + spermidine: Pterostilbene and spermidine both promote autophagy through different mechanisms (AMPK-mTOR for pterostilbene, direct eIF5A hypusination effects for spermidine). The combination may provide complementary autophagy support. Typical doses: pterostilbene 100 mg + spermidine 1 mg daily.

Pterostilbene + omega-3 fatty acids: Fish oil provides membrane EPA/DHA while pterostilbene activates lipid metabolism genes and provides antioxidant protection to polyunsaturated fatty acids. Reasonable background supplementation stack.

Pterostilbene + curcumin: Both anti-inflammatory polyphenols with complementary mechanisms. Curcumin provides NF-kB inhibition and broader inflammatory pathway modulation; pterostilbene provides SIRT1 and AMPK activation.

Pterostilbene + alpha-lipoic-acid: Both antioxidants with metabolic activity. ALA regenerates other antioxidants including vitamin C and E; pterostilbene promotes Nrf2-mediated endogenous antioxidant upregulation.

Pterostilbene + SGLT2 inhibitors (physician-supervised): Theoretical combination for metabolic optimization; clinical rationale strongest in prediabetes or metabolic syndrome contexts. Requires physician supervision.

Pterostilbene + rapamycin (caution, physician-supervised): Theoretical combination for longevity-oriented mTOR-AMPK modulation. Potential interactions and combined immune effects require physician supervision; not recommended for general use.

Stacks to avoid or use cautiously:

• Pterostilbene + antihypertensive medications: Monitor blood pressure to avoid hypotension, particularly when starting.
• Pterostilbene + anticoagulants: Theoretical enhanced bleeding risk at high pterostilbene doses; physician discussion if combined.
• Pterostilbene + statins: Monitor lipid panel due to LDL elevation signal at high pterostilbene doses; the interaction is complex and context-dependent.
• Pterostilbene + immunosuppressants (cyclosporine, tacrolimus): Theoretical CYP inhibition could increase drug levels; avoid or use only with physician supervision and drug level monitoring.
• Multiple polyphenol stack (>4 high-dose polyphenols): Accumulated CYP inhibition, antiplatelet effects, and absorption competition can produce unexpected interactions. Consolidate to 2-3 key polyphenols rather than extensive stacks.

Product selection notes:

• Most commercial pterostilbene uses ChromaDex's pTeroPure ingredient or equivalent >99% pure synthetic material.
• Pterostilbene phytosome (lecithin complex) provides further bioavailability enhancement and is available in some premium products.
• Avoid unverified-source pterostilbene; prefer products specifying pTeroPure or with third-party purity testing.
• Storage: protect from light and heat; pterostilbene is reasonably stable but not immortal. Use within labeled shelf life.

Dose-response relationships: Pterostilbene's clinical effects are generally dose-dependent within the studied range of 50-250 mg/day. Blood pressure reductions in hypertensive adults are more pronounced at 250 mg/day than at 100 mg/day. The antioxidant biomarker effects plateau earlier and do not continue scaling above 150 mg/day. The LDL cholesterol elevation signal emerges primarily at 250 mg/day and is minimal at 100 mg/day or below.

Standard supplementation doses: Most commercial products provide 50-100 mg of pterostilbene per serving, corresponding to the Basis product formulation (50 mg) or typical standalone pterostilbene products (100 mg). Clinical trial doses of 125 mg twice daily are achievable with two servings of a 125 mg product or four servings of a 50 mg product.

Bioavailability considerations: Pterostilbene's high natural oral bioavailability (70-80%) means that bioavailability enhancement technologies provide smaller relative improvements compared to poorly-bioavailable polyphenols like resveratrol (<5%) or curcumin (<1%). Nevertheless, pterostilbene phytosome formulations (lecithin complexes) provide measurable bioavailability enhancement (approximately 2-3-fold) and may reduce required doses by a similar factor. For users pursuing maximum cost-efficiency at the 100-150 mg dose range, standard pTeroPure is sufficient; phytosome formulations are useful at lower doses (50-100 mg equivalent) or where lipid absorption is compromised.

Timing: Pterostilbene's 105-minute half-life means plasma levels peak at 1-2 hours and decline substantially within 4-6 hours of a single dose. Twice-daily dosing (breakfast and dinner) provides more sustained plasma exposure than single daily dosing, but the difference in outcomes is likely modest given pterostilbene's tissue accumulation and receptor-mediated effects that persist beyond direct plasma presence. Most users take pterostilbene once daily for simplicity.

Food interaction: Pterostilbene's lipophilicity favors co-administration with meals containing some fat. Fasted administration reduces absorption approximately 30-40%. The gastrointestinal comfort benefit of fed administration (reducing nausea and stomach upset) is an additional reason to take pterostilbene with meals. The specific fat content of the meal does not dramatically affect absorption; normal meals provide adequate lipid co-administration.

Storage: Pterostilbene is relatively stable compared to some polyphenols but still benefits from storage away from direct light, heat, and moisture. Refrigeration is not required for most products; room-temperature cabinet storage is appropriate. Respect product expiration dates; degraded pterostilbene may lose activity or develop isomer variants.

Quality verification: Prefer products specifying pTeroPure ingredient or providing third-party purity testing documentation (HPLC purity >98%, absence of common adulterants, confirmed trans-isomer rather than degraded cis-isomer). Avoid products without clear sourcing or with inconsistent dosing claims.

Dosing for specific goals:

• Basic longevity support: 50 mg daily (matches Basis formulation)
• Blood pressure reduction in hypertension: 100-250 mg daily (dose at higher end of range for maximum effect; monitor lipids)
• Antioxidant and anti-inflammatory: 100-150 mg daily
• Combination with NR/NMN: 50-100 mg daily (pterostilbene as sirtuin activator paired with NAD+ precursor)
• Cognitive support: 100-150 mg daily (clinical evidence preliminary)

Not recommended doses:

• Above 250 mg daily (no additional benefit documented; LDL elevation becomes more pronounced; no basis for exceeding clinical trial doses)
• Sustained daily doses above 125 mg twice daily without lipid monitoring
• Pediatric dosing (not studied)
• Pregnancy/lactation dosing (not studied)

Loading doses or cycling: Pterostilbene does not require a loading dose; steady-state plasma levels are reached within a few days of consistent dosing. Cycling (dose-free periods) is not necessary for pterostilbene given its excellent safety profile and lack of tolerance development.